Purpose Unlimited’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$135K Sell
3,569
-170
-5% -$7.84K ﹤0.01% 265
2026
Q2
$179K Sell
3,739
-374
-9% -$16.1K 0.01% 253
2026
Q1
$151K Buy
+4,113
New +$195K 0.01% 263

Other funds holding NVO

Purpose Unlimited's NVO Position: Q3 2026 in Review

Purpose Unlimited reduced its Novo Nordisk (NVO) stake by 4.5% in Q3 2026, selling an estimated $7.84K and leaving 3,569 shares worth $135K. The position accounts for ﹤0.01% of the portfolio, ranked #265.

Purpose Unlimited first reported a position in NVO in Q1 2026 and has held it in 3 quarters since. The position peaked at $179K in Q2 2026. 1,232 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Purpose Unlimited held 3,569 shares of Novo Nordisk worth $135K as of Q3 2026.
  • Purpose Unlimited sold 170 Novo Nordisk shares in Q3 2026, an estimated $7.84K.
  • Novo Nordisk made up ﹤0.01% of Purpose Unlimited's portfolio in Q3 2026, its #265 holding.
  • Purpose Unlimited first reported a position in Novo Nordisk in Q1 2026 and has held it in 3 quarters since.
  • Purpose Unlimited's Novo Nordisk position peaked at $179K in Q2 2026.
  • 1,232 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Purpose Unlimited's 13F filing for Q3 2026, filed 12 Nov 2026.